Safety of palbociclib in breast cancer patients in the United States
Latest Information Update: 25 May 2021
At a glance
- Drugs Fulvestrant (Primary) ; Palbociclib (Primary)
- Indications Breast cancer
- Focus Adverse reactions
- 09 Dec 2020 New trial record